Literature DB >> 6321640

Persistent infection of human fibroblasts by hepatitis A virus.

A Vallbracht, L Hofmann, K G Wurster, B Flehmig.   

Abstract

Infection of human embryo fibroblasts with hepatitis A virus (HAV), a picornavirus, leads to an inapparent, persistent infection; cultures can be passed serially with consistent recovery of the virus in the supernatant. All of the cells of a HAV carrier culture are infected and proliferate. Subcultivation under HAV-immune serum cannot achieve a cure or even a reduction in the number of infected cells in HAV carrier cultures. No interferon activity can be detected during HAV infection and persistence. Addition of exogenous interferon eliminates HAV infection in vitro. Persistence of HAV in vitro appears to contradict the clinical course of HAV infection in vivo. The system presented offers the possibility of evaluating the role of immunological injury of HAV-infected cells, an injury which may lead to damage of these cells and to elimination of HAV during an HAV infection in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321640     DOI: 10.1099/0022-1317-65-3-609

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  37 in total

1.  Myelopoiesis in vitro is suppressed by hepatitis A virus.

Authors:  F W Busch; A Kunst; B Flehmig; H G Mergenthaler; G Pawelec; A Vallbracht
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

2.  Silencing of hepatitis A virus infection by small interfering RNAs.

Authors:  Yuri Kusov; Tatsuo Kanda; Ann Palmenberg; Jean-Yves Sgro; Verena Gauss-Müller
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.

Authors:  S M Lemon; P C Murphy; P A Shields; L H Ping; S M Feinstone; T Cromeans; R W Jansen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 4.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 5.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

6.  A cytopathogenic, apoptosis-inducing variant of hepatitis A virus.

Authors:  K Brack; W Frings; A Dotzauer; A Vallbracht
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA.

Authors:  Kerstin Brack; Iris Berk; Thomas Magulski; Jörg Lederer; Andreas Dotzauer; Angelika Vallbracht
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.

Authors:  Volker Fensterl; Dajana Grotheer; Iris Berk; Stefanie Schlemminger; Angelika Vallbracht; Andreas Dotzauer
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Ultrastructural and replicative features of foot-and-mouth disease virus in persistently infected BHK-21 cells.

Authors:  A Donn; M Castagnaro; A I Donaldson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.